Katrin Kupas

Katrin Kupas, a seasoned Director for Real-World Evidence with a decade of expertise in Health Technology Assessment, shares fascinating insights on integrating RWE with Joint Clinical Assessments. She emphasizes the importance of early evidence planning and when RCTs might fall short, making room for RWE. The conversation reveals the intricacies of indirect comparisons and the risks of non-randomized studies. Katrin also highlights the ROBINS-I tool for effective bias assessment, offering listeners actionable strategies to enhance their evidence generation plans.

Katrin Kupas and Jen Min-Hua discuss the role of health economics in EU HTA, the influence of joint clinical assessment on economic modeling, the need for pre-specification of statistical analyses, and the importance of statisticians having a broader perspective in health economics.